Plain-English translation of NCT06619860 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether , a new oral medication, can safely and effectively reduce the nerve pain in your lower legs and feet that develops from diabetes. Researchers will compare this medication to , a treatment that is already used for this type of pain. The goal is to understand whether the new treatment works well and has acceptable side effects.
Many people with diabetes develop painful nerve damage in their feet and legs, but current treatments don't work well for everyone or may have side effects that limit their use. This trial is exploring whether this medication offers a better option for managing this type of pain.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either at one of several dose levels or over the course of the study. You will visit the research clinic for visits where your pain levels, side effects, and overall health will be monitored. The study involves about 300 participants total, and you would receive the medication by mouth as directed by the research team.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States